Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections
Shailendra Mani, Anupamjeet Kaur, Kamini Jakhar, Geetika Kumari, Sudipta Sonar, Amit Kumar, Sudesna Das, Santosh Kumar, Vijay Kumar, Rakesh Kundu, Anil Kumar Pandey, Umesh Singh, Tanmay Majumdar
Topics & Concepts
LinagliptinDipeptidyl peptidase-4SitagliptinChemistryAvidityVildagliptinVirusDipeptidyl peptidaseVirologyViral entryCell biologyViral replicationBiologyBiochemistryEnzymeAntigenImmunologyDiabetes mellitusType 2 diabetesType 2 Diabetes MellitusEndocrinologyMetforminPeptidase Inhibition and AnalysisNeuropeptides and Animal PhysiologyAntimicrobial Peptides and Activities